The role of regulatory T cells during the attenuation of graft-versus-leukemia activity following donor leukocyte infusion in mice

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

We investigated how the graft-versus-leukemia (GVL) effect is attenuated in the tumor microenvironment using a murine model of non-myeloablative allo-HSCT (NM-HSCT) plus delayed donor leukocyte infusion (DLI) in a haploidentical B6→F1 strain combination. In-line with aggravated leukemia growth, the proportions of effector T cells expressing IFN-γ (Teffs) in spleen were reduced and attenuated GVL activity was found to be accompanied by a rebound in CD4 +Foxp3 + regulatory T cells (Tregs) in tumor-draining lymph nodes and tumor tissues. DLI-derived Tregs and Teffs may be potential indicators of presence of leukemic progression after DLI in this GVL model.

Original languageEnglish
Pages (from-to)1549-1556
Number of pages8
JournalLeukemia Research
Volume35
Issue number12
DOIs
StatePublished - Dec 2011

Bibliographical note

Funding Information:
This study was supported by the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs , Republic of Korea (grant no. A092258 ).

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-host disease
  • Graft-versus-leukemia effect
  • Regulatory T cells
  • TGF-β

Fingerprint

Dive into the research topics of 'The role of regulatory T cells during the attenuation of graft-versus-leukemia activity following donor leukocyte infusion in mice'. Together they form a unique fingerprint.

Cite this